Sound Stops Stress Study: Evaluating the WAVwatch Effect
1 other identifier
interventional
100
1 country
1
Brief Summary
Sound Off Stress Study seeks to discover if WAVwatch 2.0-a sleek, wearable sound frequency device-can support mental harmony.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 25, 2025
CompletedFirst Submitted
Initial submission to the registry
December 5, 2025
CompletedFirst Posted
Study publicly available on registry
December 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 25, 2026
December 23, 2025
December 1, 2025
1 year
December 5, 2025
December 19, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Perceived Stress Scale (Past Week Version)
The Perceived Stress Scale (Past Week Version) is a modified version of the classic stress assessment tool that evaluates stress levels based on recent experiences within the last week. This scale helps in understanding how various situations have recently affected an individual's feelings and perceived stress levels. By focusing on a shorter time frame, it provides a more immediate assessment of stress, which can be particularly useful for quickly evaluating the effectiveness of stress management strategies or interventions. The tool retains its original structure, ensuring its reliability while making it more relevant for current stress evaluation.
Change from baseline (Day 1-3) in perceived stress levels at 4 weeks after the start of the intervention (Day 27-33)
General Anxiety Disorder (GAD-7)
The GAD-7 is a 7-item questionnaire used to assess the severity of generalized anxiety disorder (GAD) in adults. The score is based on the responses to seven questions about the frequency of common anxiety symptoms over the past two weeks.
Change from baseline (Day 1-3) in anxiety severity at 4 weeks after the start of the intervention (Day 27-33)
NIH Toolbox® Item Bank v3.0 - General Life Satisfaction (Ages 18+)
This is a survey aimed at assessing the general life satisfaction of individuals aged 18 and above. Participants are asked a series of questions to which they can respond by indicating their level of agreement or disagreement.
Change from baseline (Day 1-3) in general life satisfaction at 4 weeks after the start of the intervention (Day 27-33)
Depression, Anxiety and Stress Scales (DASS-21) Survey
The Depression, Anxiety, and Stress Scales (DASS-21) is a widely recognized psychological assessment tool designed to measure the severity of symptoms related to depression, anxiety, and stress. It consists of 21 questions that assess various emotional and psychological factors. Participants are asked to rate the frequency and intensity of their experiences over the past week. The DASS-21 survey provides a quick and reliable way for clinicians, researchers, and individuals to gauge their levels of depression, anxiety, and stress, making it a valuable instrument for mental health assessment and research.
Change from baseline (Day 1-3) in depression, anxiety, and stress levels at 4 weeks after the start of the intervention (Day 27-33)
Study Arms (1)
Single arm where participants act as their own control
EXPERIMENTALSingle arm where participants act as their own control
Interventions
The WAVwatch 2.0, a wrist-worn device intervention, leverages 'calming' frequencies to reduce stress and non-clinically relevant anxiety, aligning with scientific evidence supporting sound therapy's potential.
Eligibility Criteria
You may qualify if:
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
You may not qualify if:
- Individuals with skin sensitivities
- Individuals with auditory conditions
- Individuals with severe anxiety or mental health disorders
- Pregnancy
- Individuals prone to irritation or frustration
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Efforia, Inclead
Study Sites (1)
Efforia
New York, New York, 10003, United States
Related Links
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2025
First Posted
December 15, 2025
Study Start
August 25, 2025
Primary Completion (Estimated)
August 25, 2026
Study Completion (Estimated)
August 25, 2026
Last Updated
December 23, 2025
Record last verified: 2025-12